Clinical Trial: Ovicidal Efficacy and Safety of Abametapir Lotion 0.74% Administered for the Treatment of Head Lice Infestation
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Randomised, Double-Blind, Vehicle-Controlled Study of Ovicidal Efficacy and Safety of Abametapir 0.74% Administered for the Treatment of Head Lice Infestation
Brief Summary: The purpose of the study is to evaluate ovicidal efficacy of a single application of abametapir lotion 0.74% w/w intended for the treatment of head lice.
Detailed Summary:
Sponsor: Hatchtech Pty Ltd
Current Primary Outcome: Proportion of hatched eggs pre treatment relative to proportion of hatched eggs post treatment for the abametapir and vehicle treated eggs following 14 day incubation. [ Time Frame: 14 days ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Hatchtech Pty Ltd
Dates:
Date Received: March 24, 2014
Date Started: May 2014
Date Completion:
Last Updated: March 15, 2016
Last Verified: March 2016